Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction
Authors:
- Eleni VrigkouEVEleni Vrigkou
- Argyrios E. TsantesArgyrios E. Tsantes
- Petros KopteridesPKPetros Kopterides
- Stylianos E. OrfanosSOStylianos E. Orfanos
- Apostolos ArmaganidisAAApostolos Armaganidis
- Eirini MaratouEMEirini Maratou
- Evdoxia RaptiEREvdoxia Rapti
- Athanasios PappasAPAthanasios Pappas
- Andreas G. TsantesAndreas G. Tsantes
- Iraklis TsangarisIraklis Tsangaris
Open Access
- 27 September 2020
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 10 (10) , 758
Abstract
Many pathophysiologic processes of pulmonary arterial hypertension (PAH), namely, excess vasoconstriction, vascular remodeling and in situ thrombosis, involve the coagulation cascade, and more specifically, platelets. The aim of this study was to globally assess coagulation processes in PAH, by using non-conventional hemostatic tests, along with markers of platelet activation and endothelial dysfunction. We studied 44 new PAH patients (22 with idiopathic PAH and 22 with connective tissue disease) and 25 healthy controls. The following tests were performed: platelet function analyzer-100 (PFA-100), light transmission aggregometry (LTA), rotational thromboelastometry (ROTEM), endogenous thrombin potential (ETP), serotonin, thromboxane A2 and p-selectin plasma levels, and von Willebrand antigen (VWF:Ag) and activity (VWF:Ac). Our results showed that PAH patients had diminished platelet aggregation, presence of disaggregation, defective initiation of the clotting process and clot propagation, and diminished thrombin formation capacity. Serotonin, thromboxane A2 and p-selectin levels were increased, and VWF:Ag and VWF:Ac decreased in the same population. The results of this study suggest that the platelets of PAH patients are activated and present functional abnormalities. The procoagulant activity, in general, appears to be impaired probably due to a sustained and prolonged activation of the procoagulant processes. Larger observational studies are warranted to confirm these laboratory findings.Keywords
This publication has 42 references indexed in Scilit:
- Rotational thromboelastometry and standard coagulation tests for live liver donorsClinical Transplantation, 2013
- Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery diseaseThrombosis Research, 2012
- Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertensionEuropean Respiratory Journal, 2012
- Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertensionThrombosis Research, 2010
- Diagnosis and Management of Inherited Platelet DisordersTransfusion Medicine and Hemotherapy, 2010
- The Paradox of Platelet Activation and Impaired Function: Platelet-von Willebrand Factor Interactions, and the Etiology of Thrombotic and Hemorrhagic Manifestations in Essential Thrombocythemia and Polycythemia VeraSeminars in Thrombosis and Hemostasis, 2006
- Determination of von Willebrand Factor Activity: Evaluation of the HaemosIL™ Assay in Comparison With Established ProceduresClinical and Applied Thrombosis/Hemostasis, 2006
- The platelet release reaction: granules' constituents, secretion and functionsPlatelets, 2001
- Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation, 1984
- Acquired dysfunction due to the circulation of “exhausted” plateletsThe American Journal of Medicine, 1980